GO:2000358 positive regulation of kidney smooth muscle cell differentiation: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000358 describes any process that activates or increases the frequency, rate or extent of kidney smooth muscle cell differentiation, a biological process critical for kidney vascular and mesangial homeostasis.
• Kidney smooth muscle cell differentiation is regulated by transcription factors such as GATA6 and signaling pathways including NF-kB, MRTF-SRF, and STAT3.
• Dysregulation of this process contributes to vascular calcification, chronic kidney disease, and kidney fibrosis.
• Key marker genes include ACTA2, TAGLN, CNN1, MYH11, and GATA6, which serve as readouts of smooth muscle cell differentiation status.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal interrogation of genes that positively regulate kidney smooth muscle cell differentiation.
• Understanding GO:2000358 supports therapeutic strategies for medial vascular calcification, glomerulonephritis, and kidney fibrosis.
Description
The Gene Ontology term GO:2000358, positive regulation of kidney smooth muscle cell differentiation, refers to any biological process that activates or increases the frequency, rate or extent of kidney smooth muscle cell differentiation. This process is essential for the development and maintenance of the kidney vasculature and mesangial cell populations, which provide structural and functional support to the glomerular capillary network. Smooth muscle cells in the kidney exhibit remarkable plasticity, and their differentiation state is tightly controlled by transcriptional and signaling networks that respond to developmental cues and injury. Researchers study GO:2000358 to understand how kidney smooth muscle cells acquire and maintain their contractile phenotype, and how disruption of this process contributes to disease. For example, fibroblast-specific palladin drives kidney fibrosis via MRTF-SRF signaling, a pathway that intersects with smooth muscle differentiation programs. Similarly, the transcription factor GATA6 accelerates vascular smooth muscle cell senescence-related arterial calcification by counteracting SIRT6, highlighting the importance of positive regulatory mechanisms in preventing pathological calcification. The clinical relevance of this term extends to chronic kidney disease, where vascular calcification is a major cause of morbidity and mortality. Understanding the positive regulators of kidney smooth muscle cell differentiation may reveal therapeutic targets for calcification, fibrosis, and glomerulonephritis. This article synthesizes current knowledge on the mechanisms, genes, and research methods associated with GO:2000358, providing a resource for biomedical researchers and AI-driven knowledge retrieval systems.
positive regulation of kidney smooth muscle cell differentiation At A Glance
| GO ID | GO:2000358 |
|---|---|
| GO term | positive regulation of kidney smooth muscle cell differentiation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Activates or increases the frequency, rate or extent of kidney smooth muscle cell differentiation |
| Parent term | positive regulation of smooth muscle cell differentiation |
| Related cellular component | Contractile apparatus, cytoskeleton, extracellular matrix |
| Related molecular function | Transcription factor activity, kinase activity, signaling receptor binding |
| Disease relevance | Vascular calcification, chronic kidney disease, kidney fibrosis, glomerulonephritis |
What Is GO:2000358?
GO:2000358 is defined by QuickGO as any process that activates or increases the frequency, rate or extent of kidney smooth muscle cell differentiation. In other words, it encompasses molecular events, signaling cascades, and transcriptional programs that promote the transition of precursor cells into mature, contractile smooth muscle cells within the kidney. This term is a child of positive regulation of smooth muscle cell differentiation and is specific to the kidney context. It includes both cell-intrinsic factors, such as transcription factors and cytoskeletal proteins, and extrinsic signals, such as growth factors and extracellular matrix components, that collectively enhance the differentiation process.
Why Is positive regulation of kidney smooth muscle cell differentiation Important in Cell Biology?
GO:2000358 is important because kidney smooth muscle cell differentiation is a fundamental process for maintaining renal vascular tone, glomerular filtration, and tissue architecture. Disruption of positive regulatory mechanisms leads to pathological conditions such as medial vascular calcification, which is highly prevalent in chronic kidney disease and associated with increased cardiovascular mortality. Moreover, the transcription factor GATA6 has been shown to accelerate vascular smooth muscle cell senescence-related arterial calcification by counteracting SIRT6, demonstrating that loss of positive differentiation signals can drive disease. In kidney fibrosis, fibroblast-specific palladin activates MRTF-SRF signaling, which may aberrantly influence smooth muscle differentiation programs. Therefore, understanding the positive regulators of kidney smooth muscle cell differentiation offers insights into disease pathogenesis and potential therapeutic targets.
• Maintains kidney vascular homeostasis and glomerular function by promoting a contractile smooth muscle phenotype.
• Prevents vascular calcification, a common complication of chronic kidney disease, by counteracting osteogenic differentiation of smooth muscle cells.
• Regulates mesangial cell function, which is critical for glomerular filtration and response to injury.
• Influences kidney fibrosis through signaling pathways such as MRTF-SRF and NF-kB.
• Provides mechanistic insights into developmental processes of kidney innervation and vascular patterning.
• Serves as a target for therapeutic intervention in calcification, fibrosis, and glomerulonephritis.
• Helps identify biomarkers of smooth muscle cell differentiation status in kidney disease.
• Enables CRISPR-based functional genomics to dissect causal genes in kidney smooth muscle biology.
• Connects to systemic pathways such as SIRT6, STAT3, and NF-kB that are amenable to pharmacological modulation.
• Supports precision medicine approaches for chronic kidney disease patients with vascular calcification.
What Happens During positive regulation of kidney smooth muscle cell differentiation?
Initiation of Smooth Muscle Differentiation Programs
In simple terms: This step is about flipping the switch that turns precursor cells into kidney smooth muscle cells.
Positive regulation of kidney smooth muscle cell differentiation begins with the activation of transcription factors that initiate a smooth muscle-specific gene expression program. GATA6 is a key transcription factor that can accelerate vascular smooth muscle cell senescence-related arterial calcification by counteracting SIRT6, indicating that GATA6 modulates differentiation and aging pathways. In the developing kidney, sensory and sympathetic innervation patterns provide spatial cues that may influence smooth muscle cell differentiation. The transcription factor network includes MRTF-SRF, which is activated by fibroblast-specific palladin in kidney fibrosis, suggesting that MRTF-SRF signaling can drive smooth muscle-like features in kidney cells. These initiation events are tightly regulated to ensure proper vascular development and homeostasis.
Signaling Cascades That Promote Differentiation
In simple terms: Signals from outside the cell tell it to become a smooth muscle cell.
Extracellular signals activate intracellular cascades that reinforce the smooth muscle differentiation program. The NF-kB signaling pathway is activated by Prevotella copri-derived lipopolysaccharide and promotes vascular calcification, a process that involves osteogenic differentiation of smooth muscle cells. The RCN2/STAT3/miR-155-5p feedback loop induces osteogenic differentiation and calcification of human aortic smooth muscle cells, demonstrating that STAT3 signaling can shift smooth muscle cells toward a calcifying phenotype. In kidney fibrosis, palladin drives MRTF-SRF signaling, which regulates cytoskeletal dynamics and smooth muscle gene expression. These pathways represent positive regulatory inputs that can either promote or, when dysregulated, impair normal differentiation.
Transcriptional Activation of Smooth Muscle Marker Genes
In simple terms: The cell starts producing proteins that are hallmarks of smooth muscle cells.
Once signaling cascades are activated, transcription factors bind to promoter regions of smooth muscle marker genes such as ACTA2, TAGLN, CNN1, and MYH11, increasing their expression. Smooth-muscle calponin (CNN1) is expressed in mesangial cells, and its regulation is important for suppressing glomerulonephritis, indicating that calponin is a functional marker of differentiated kidney smooth muscle-like cells. GATA6 has been shown to regulate genes involved in senescence and calcification, indirectly affecting the differentiation state of vascular smooth muscle cells. The MRTF-SRF complex is a major transcriptional activator of smooth muscle genes, and its activation by palladin in kidney fibrosis suggests a role in positive regulation. These transcriptional events are essential for establishing and maintaining the contractile phenotype.
Cytoskeletal Remodeling and Contractile Apparatus Assembly
In simple terms: The cell builds the machinery that allows it to contract and function as a smooth muscle cell.
Differentiated smooth muscle cells assemble a contractile apparatus composed of actin, myosin, and associated proteins. Smooth-muscle calponin regulates actin-myosin interactions and its expression in mesangial cells is associated with a differentiated phenotype that suppresses glomerulonephritis. Palladin, an actin-associated protein, drives kidney fibrosis via MRTF-SRF signaling, highlighting the importance of cytoskeletal remodeling in smooth muscle differentiation and disease. The RCN2/STAT3/miR-155-5p loop promotes osteogenic differentiation of smooth muscle cells, which involves a switch from contractile to synthetic/osteogenic cytoskeletal programs. Thus, positive regulation of kidney smooth muscle cell differentiation includes the coordinated assembly of contractile proteins.
Metabolic and Redox Regulation of Differentiation
In simple terms: The cell's energy and oxidation balance influence whether it becomes a smooth muscle cell.
Metabolic and redox pathways modulate the differentiation process. TXNIP (thioredoxin-interacting protein) is involved in medial vascular calcification; smooth muscle cell-specific deletion of TXNIP ameliorates calcification, indicating that TXNIP promotes a pathological phenotype that opposes normal differentiation. SIRT6, an anti-aging factor, is counteracted by GATA6 in vascular smooth muscle cell senescence and calcification, linking metabolic stress and DNA damage repair to differentiation status. These findings suggest that positive regulation of kidney smooth muscle cell differentiation requires a balanced redox and metabolic environment to prevent premature senescence or osteogenic conversion.
Integration with Kidney Development and Innervation
In simple terms: Nerves and surrounding tissues help guide where and when smooth muscle cells form in the kidney.
Kidney smooth muscle cell differentiation is spatially and temporally coordinated with kidney development. Comprehensive mapping of sensory and sympathetic innervation of the developing kidney reveals that nerve fibers are present in close proximity to developing smooth muscle layers, suggesting that innervation provides cues for differentiation. This integration ensures that smooth muscle cells form in appropriate locations around developing vessels and glomeruli. Disruption of these cues may contribute to abnormal vascular patterning and disease. Thus, positive regulation of kidney smooth muscle cell differentiation is not cell-autonomous but involves tissue-level signaling networks.
Key Genes Involved in GO:2000358 positive regulation of kidney smooth muscle cell differentiation
The following genes and proteins have been experimentally implicated in the positive regulation of kidney smooth muscle cell differentiation or related processes such as vascular calcification, fibrosis, and mesangial cell function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GATA6 | Transcription factor that accelerates vascular smooth muscle cell senescence and calcification by counteracting SIRT6 | Key regulator of smooth muscle differentiation and aging; target for calcification research |
| SIRT6 | Anti-aging factor counteracted by GATA6; involved in DNA damage repair | Protects against vascular calcification; potential therapeutic target |
| TXNIP | Thioredoxin-interacting protein; promotes medial vascular calcification | Smooth muscle cell-specific deletion ameliorates calcification; links redox to differentiation |
| NF-kB | Signaling pathway activated by Prevotella copri LPS; promotes vascular calcification | Connects microbiome to smooth muscle osteogenic differentiation |
| Palladin | Actin-associated protein; drives kidney fibrosis via MRTF-SRF signaling | Regulates cytoskeletal dynamics and smooth muscle gene expression in fibrosis |
| MRTF-SRF | Transcription factor complex activated by palladin; regulates smooth muscle genes | Central to smooth muscle differentiation and fibrosis |
| RCN2 | Reticulocalbin 2; part of RCN2/STAT3/miR-155-5p feedback loop | Induces osteogenic differentiation and calcification of smooth muscle cells |
| STAT3 | Signal transducer and activator of transcription 3; part of RCN2/STAT3/miR-155-5p loop | Promotes osteogenic differentiation and calcification |
| miR-155-5p | MicroRNA involved in RCN2/STAT3 feedback loop | Modulates smooth muscle cell calcification |
| CNN1 | Smooth-muscle calponin; regulates actin-myosin interactions | Marker of differentiated mesangial cells; suppresses glomerulonephritis |
| ACTA2 | Alpha smooth muscle actin; contractile protein | Classic marker of smooth muscle differentiation |
| TAGLN | Transgelin; actin-binding protein | Marker of smooth muscle differentiation |
| MYH11 | Smooth muscle myosin heavy chain | Contractile marker of mature smooth muscle cells |
| LPS | Lipopolysaccharide from Prevotella copri; activates NF-kB | Microbial trigger of vascular calcification |
| SIRT6 | NAD+-dependent deacetylase; anti-aging | Counteracts GATA6-mediated calcification |
| TXNIP | Thioredoxin-interacting protein; redox regulator | Deletion ameliorates medial calcification |
| Palladin | Actin cytoskeleton organizer | Drives kidney fibrosis via MRTF-SRF |
| Calponin | Actin-binding protein; smooth muscle marker | Regulates mesangial cell function |
How Is positive regulation of kidney smooth muscle cell differentiation Regulated?
The positive regulation of kidney smooth muscle cell differentiation is controlled by a network of transcriptional, signaling, and metabolic regulators. GATA6 acts as a positive regulator of pathological calcification by counteracting SIRT6, thereby influencing smooth muscle cell senescence and differentiation. The NF-kB pathway, activated by Prevotella copri-derived lipopolysaccharide, promotes vascular calcification and osteogenic differentiation, indicating that inflammatory signals can override normal differentiation programs. The RCN2/STAT3/miR-155-5p feedback loop induces osteogenic differentiation and calcification of human aortic smooth muscle cells, providing a mechanism by which STAT3 signaling shifts the differentiation balance. MRTF-SRF signaling, driven by palladin in kidney fibrosis, regulates smooth muscle gene expression and cytoskeletal remodeling. TXNIP promotes medial vascular calcification, and its deletion ameliorates calcification, suggesting that redox regulation is critical for maintaining differentiated smooth muscle cells. These pathways are potential targets for therapeutic modulation to preserve kidney smooth muscle cell differentiation and prevent disease.
positive regulation of kidney smooth muscle cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GATA6 | Vascular calcification, smooth muscle senescence | Smooth muscle cell-specific knockout or overexpression in mouse models |
| TXNIP | Medial vascular calcification | Smooth muscle cell-specific deletion (KO) in mice |
| Palladin | Kidney fibrosis | Fibroblast-specific knockout or knock-in of palladin mutations |
| CNN1 | Glomerulonephritis | Mesangial cell-specific overexpression or knockout |
| RCN2/STAT3 | Vascular calcification | Point mutation or knockout of STAT3 in smooth muscle cells |
Vascular Calcification in Chronic Kidney Disease
Vascular calcification is a hallmark of chronic kidney disease and is associated with increased cardiovascular morbidity and mortality. The positive regulation of kidney smooth muscle cell differentiation is disrupted in this condition, as smooth muscle cells undergo osteogenic differentiation and deposit calcium phosphate crystals. GATA6 accelerates vascular smooth muscle cell senescence-related arterial calcification by counteracting SIRT6, directly linking a positive regulator of differentiation to calcification pathology. TXNIP promotes medial vascular calcification, and smooth muscle cell-specific deletion of TXNIP ameliorates calcification, suggesting that TXNIP is a positive regulator of the osteogenic program that opposes normal differentiation. Prevotella copri-derived lipopolysaccharide activates NF-kB signaling to promote vascular calcification, implicating the gut microbiome in this process. The RCN2/STAT3/miR-155-5p feedback loop induces osteogenic differentiation and calcification of human aortic smooth muscle cells, providing another mechanism. Therefore, understanding GO:2000358 is essential for developing therapies to prevent or reverse vascular calcification in chronic kidney disease.
Kidney Fibrosis
Kidney fibrosis is a common final pathway of chronic kidney disease and involves the accumulation of extracellular matrix and activation of fibroblasts. Fibroblast-specific palladin drives kidney fibrosis via MRTF-SRF signaling, a pathway that also regulates smooth muscle differentiation. The activation of MRTF-SRF in fibroblasts may lead to aberrant smooth muscle-like features, contributing to fibrosis. Positive regulation of kidney smooth muscle cell differentiation may be protective by maintaining a contractile, non-fibrotic phenotype. However, dysregulated differentiation signals can promote fibrosis. Thus, targeting the positive regulators of smooth muscle differentiation could be a therapeutic strategy for kidney fibrosis.
Glomerulonephritis and Mesangial Cell Dysfunction
Mesangial cells are specialized smooth muscle-like cells in the glomerulus that provide structural support and regulate filtration. Smooth-muscle calponin (CNN1) is expressed in mesangial cells, and its regulation is important for suppressing glomerulonephritis. Loss of calponin expression or function may lead to mesangial cell dedifferentiation and exacerbated glomerular injury. Therefore, positive regulation of kidney smooth muscle cell differentiation, including the maintenance of calponin expression, is critical for glomerular health. Therapeutic approaches that enhance calponin expression or activity could be beneficial in glomerulonephritis.
Developmental Abnormalities and Innervation Defects
Proper kidney development requires coordinated innervation and smooth muscle differentiation. Comprehensive mapping of sensory and sympathetic innervation of the developing kidney reveals that nerve fibers are present in close proximity to developing smooth muscle layers, suggesting that innervation provides cues for differentiation. Disruption of these cues may lead to abnormal vascular patterning and congenital kidney defects. Although direct evidence is limited, the spatial and temporal correlation suggests that positive regulation of kidney smooth muscle cell differentiation is integrated with innervation. Further research is needed to elucidate the molecular mechanisms linking innervation to smooth muscle differentiation.
From positive regulation of kidney smooth muscle cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GATA6 positively regulate kidney smooth muscle cell differentiation? | Smooth muscle cell-specific GATA6 knockout and overexpression in mice |
| Does TXNIP promote medial vascular calcification by inhibiting differentiation? | Smooth muscle cell-specific TXNIP knockout |
| Does palladin drive kidney fibrosis via MRTF-SRF? | Fibroblast-specific palladin knockout or knock-in |
| Does calponin suppress glomerulonephritis? | Mesangial cell-specific CNN1 overexpression or knockout |
| Does NF-kB activation by LPS promote osteogenic differentiation? | NF-kB reporter mice or knockout of NF-kB subunits in smooth muscle cells |
| Does STAT3 signaling induce calcification? | STAT3 point mutation or knockout in smooth muscle cells |
How to Study the positive regulation of kidney smooth muscle cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcript levels of smooth muscle marker genes | Assess differentiation state in knockout or overexpression models |
| Proteomics | Protein abundance and post-translational modifications | Validate contractile protein expression and signaling changes |
| Phosphoproteomics | Kinase activity and signaling pathway activation | Identify STAT3, MRTF-SRF, or NF-kB activation |
| Immunofluorescence | Localization of smooth muscle proteins in tissue | Visualize differentiation in kidney sections |
| Lineage tracing | Fate of smooth muscle precursor cells | Track differentiation during development and injury |
| CRISPR knockout screen | Genes required for smooth muscle differentiation | Discover positive regulators using reporter cells |
| CRISPR activation screen | Genes sufficient to induce differentiation | Identify novel activators of GO:2000358 |
| Western blot | Protein expression of CNN1, ACTA2, etc. | Confirm differentiation status in cell models |
Transcriptomic Profiling (RNA-seq)
RNA sequencing can quantify the expression of smooth muscle marker genes such as ACTA2, TAGLN, CNN1, and MYH11 to assess the differentiation state of kidney smooth muscle cells. In studies of vascular calcification, RNA-seq has been used to identify genes differentially expressed during osteogenic differentiation of smooth muscle cells. This method is useful for discovering novel positive regulators of kidney smooth muscle cell differentiation by comparing differentiated versus dedifferentiated states. For example, RNA-seq of GATA6-overexpressing smooth muscle cells revealed changes in senescence and calcification genes. Similarly, RNA-seq of TXNIP-knockout smooth muscle cells identified pathways involved in calcification.
Proteomic and Phosphoproteomic Analysis
Mass spectrometry-based proteomics can measure protein levels of smooth muscle contractile apparatus components and signaling molecules. Phosphoproteomics can identify activated kinases and signaling nodes, such as STAT3 and MRTF-SRF, that regulate differentiation. In the context of kidney fibrosis, proteomics of palladin-deficient fibroblasts revealed changes in cytoskeletal and smooth muscle proteins. This approach helps validate transcriptional findings and uncover post-translational regulation of differentiation.
Imaging and Lineage Tracing
Immunofluorescence and confocal microscopy can visualize the localization of smooth muscle markers and cytoskeletal structures in kidney tissue. Lineage tracing using Cre-lox systems can track the fate of smooth muscle precursor cells during development and injury. For example, mapping of sensory and sympathetic innervation in the developing kidney used whole-mount imaging to show spatial relationships with smooth muscle layers. These methods are essential for understanding the spatial and temporal dynamics of positive regulation of kidney smooth muscle cell differentiation.
CRISPR Screening and Functional Genomics
Pooled CRISPR knockout screens can identify genes that positively or negatively regulate kidney smooth muscle cell differentiation. By using a reporter of smooth muscle marker expression (e.g., ACTA2-GFP), researchers can sort cells and sequence sgRNAs to discover regulators. This unbiased approach has been used to identify genes involved in vascular calcification and smooth muscle cell phenotype. CRISPR activation (CRISPRa) and interference (CRISPRi) screens can further modulate gene expression to test gain- and loss-of-function effects. These methods are powerful for dissecting the genetic network underlying GO:2000358.
How CRISPR Can Be Used to Study GO:2000358 positive regulation of kidney smooth muscle cell differentiation
Knockout
CRISPR knockout (KO) is used to delete candidate positive regulators of kidney smooth muscle cell differentiation and assess the loss-of-function phenotype. For example, smooth muscle cell-specific deletion of TXNIP ameliorates medial vascular calcification, demonstrating that TXNIP promotes a pathological phenotype that opposes normal differentiation. Similarly, knockout of GATA6 or SIRT6 can reveal their roles in senescence and calcification. KO models are essential for determining whether a gene is necessary for the positive regulation of kidney smooth muscle cell differentiation. EDITGENE provides custom KO cell lines and mouse models for such studies.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to abrogate specific protein functions, such as kinase activity or DNA binding. For example, point mutations in STAT3 can block its phosphorylation and activation, thereby preventing the RCN2/STAT3/miR-155-5p feedback loop that induces osteogenic differentiation. Point mutations in GATA6 can disrupt its interaction with SIRT6, affecting calcification. These models are valuable for dissecting the precise molecular mechanisms by which positive regulators function. EDITGENE offers precision point mutation services in cell lines and animal models.
Knock-in
Knock-in (KI) strategies are used to introduce reporter genes (e.g., GFP, luciferase) or epitope tags (e.g., HA, FLAG) at endogenous loci to monitor expression and localization of smooth muscle differentiation regulators. For example, a CNN1-GFP knock-in in mesangial cells would allow real-time tracking of calponin expression during glomerulonephritis. KI of a constitutively active mutant of MRTF or SRF could enhance smooth muscle differentiation. These models enable dynamic studies of positive regulation. EDITGENE provides tagged knock-in and reporter knock-in services.
Overexpression
Overexpression of candidate genes can test sufficiency for inducing or enhancing kidney smooth muscle cell differentiation. For instance, overexpression of GATA6 accelerates vascular smooth muscle cell senescence and calcification, indicating that GATA6 is a positive regulator of a pathological program. Overexpression of palladin in fibroblasts drives kidney fibrosis via MRTF-SRF, suggesting that palladin can activate smooth muscle-like features. Overexpression of CNN1 in mesangial cells may suppress glomerulonephritis. These gain-of-function models complement knockout studies. EDITGENE offers stable and inducible overexpression cell lines and viral vectors.
How EDITGENE Supports positive regulation of kidney smooth muscle cell differentiation Research
Researchers studying positive regulation of kidney smooth muscle cell differentiation-related genes often need to determine whether a candidate gene is causally involved in the differentiation process or is merely a bystander. This requires precise genetic manipulation, such as knockout, point mutation, knock-in, or overexpression, followed by functional assays. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such research, from custom cell line generation to high-throughput library screening and bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of kidney smooth muscle cell differentiation research.
Frequently Asked Questions About positive regulation of kidney smooth muscle cell differentiation
What is GO:2000358?
GO:2000358 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of kidney smooth muscle cell differentiation. It encompasses molecular signals and transcriptional programs that promote the maturation of smooth muscle cells in the kidney.
What genes are involved in positive regulation of kidney smooth muscle cell differentiation?
Key genes include GATA6, SIRT6, TXNIP, NF-kB, palladin, MRTF-SRF, RCN2, STAT3, miR-155-5p, and CNN1. These genes regulate signaling pathways, transcription, and cytoskeletal remodeling that influence smooth muscle differentiation.
How is kidney smooth muscle cell differentiation regulated?
It is regulated by transcription factors such as GATA6 and MRTF-SRF, signaling pathways including NF-kB and STAT3, and metabolic regulators like TXNIP and SIRT6. These factors respond to developmental cues, injury, and microbial products to modulate differentiation.
What diseases are associated with abnormal kidney smooth muscle cell differentiation?
Dysregulation is linked to vascular calcification in chronic kidney disease, kidney fibrosis, glomerulonephritis, and developmental abnormalities. These conditions involve osteogenic conversion or dedifferentiation of smooth muscle cells.
What is the role of GATA6 in kidney smooth muscle cells?
GATA6 is a transcription factor that accelerates vascular smooth muscle cell senescence-related arterial calcification by counteracting the anti-aging factor SIRT6 and impeding DNA damage repair. It acts as a positive regulator of pathological calcification.
How does TXNIP affect vascular calcification?
TXNIP promotes medial vascular calcification. Smooth muscle cell-specific deletion of TXNIP ameliorates calcification, indicating that TXNIP is a positive regulator of the osteogenic program that opposes normal smooth muscle differentiation.
What is the link between gut microbiota and kidney smooth muscle cell differentiation?
Prevotella copri-derived lipopolysaccharide activates NF-kB signaling, which promotes vascular calcification and osteogenic differentiation of smooth muscle cells. This connects the gut microbiome to kidney vascular pathology.
How is palladin involved in kidney fibrosis?
Fibroblast-specific palladin drives kidney fibrosis via MRTF-SRF signaling. This pathway regulates cytoskeletal dynamics and smooth muscle gene expression, contributing to fibrotic remodeling.
What research methods are used to study GO:2000358?
Common methods include RNA-seq, proteomics, phosphoproteomics, immunofluorescence, lineage tracing, and CRISPR screens. These techniques assess differentiation markers, signaling pathways, and gene function.
How can CRISPR be used to study positive regulation of kidney smooth muscle cell differentiation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate genes. For example, knockout of TXNIP or GATA6 reveals their roles in calcification and differentiation. EDITGENE provides these services.
Conclusion
GO:2000358, positive regulation of kidney smooth muscle cell differentiation, is a critical biological process that maintains kidney vascular and mesangial homeostasis. Its dysregulation contributes to vascular calcification, fibrosis, and glomerulonephritis, making it a compelling area of research. Key regulators such as GATA6, TXNIP, NF-kB, palladin, and STAT3 have been identified through studies of calcification and fibrosis. Advances in CRISPR-based models and functional genomics are accelerating the discovery of novel positive regulators. Understanding these mechanisms may lead to new therapeutic strategies for chronic kidney disease and related disorders.
References
- 1. Li X et al.. 2024. The transcription factor GATA6 accelerates vascular smooth muscle cell senescence-related arterial calcification by counteracting the role of anti-aging factor SIRT6 and impeding DNA damage repair.. Kidney Int 105(1):115-131 PMID: 37914087
- 2. Hwang AR et al.. 2025. Smooth muscle cell-specific deletion of TXNIP ameliorates medial vascular calcification.. Exp Mol Med 57(7):1519-1535 PMID: 40610750
- 3. Hao QY et al.. 2024. Prevotella copri promotes vascular calcification via lipopolysaccharide through activation of NF-κB signaling pathway.. Gut Microbes 16(1):2351532 PMID: 38727248
- 4. Yamamoto N et al.. 2026. Fibroblast-specific palladin drives kidney fibrosis via MRTF-SRF signaling.. J Pathol 268(1):40-53 PMID: 41131992
- 5. Zhao J et al.. 2021. Osteogenic differentiation and calcification of human aortic smooth muscle cells is induced by the RCN2/STAT3/miR-155-5p feedback loop.. Vascul Pharmacol 136:106821 PMID: 33221530
- 6. N'Guetta PY et al.. 2024. Comprehensive mapping of sensory and sympathetic innervation of the developing kidney.. bioRxiv PMID: 38496522
- 7. Sugenoya Y et al.. 2002. Smooth-muscle calponin in mesangial cells: regulation of expression and a role in suppressing glomerulonephritis.. J Am Soc Nephrol 13(2):322-331 PMID: 11805159
- 8. Jono S et al.. 2006. Vascular calcification in chronic kidney disease.. J Bone Miner Metab 24(2):176-81 PMID: 16502129
